DR. ISAAC GABRIEL ELIAZ, MD
Medical Practice at Corline Ct, Sebastopol, CA
License number
California A73390
Category
Medical Practice
Type
Public Health & General Preventive Medicine
Address
Address
7064 Corline Ct SUITE A, Sebastopol, CA 95472
Phone
(707) 829-5900
(707) 829-5282 (Fax)
(707) 829-5282 (Fax)
Professional information
Isaac Gabriel Eliaz, Sebastopol CA
Specialties:
General Practice, Allergy & Immunology, Family Medicine, Preventive Medicine, Public Health & General Preventive Medicine
Work:
Amitabha Medical Clinic & Healing Center
7064 Corline Ct, Sebastopol, CA 95472
7064 Corline Ct, Sebastopol, CA 95472
Education:
Sackler School Of Medicine (1988)
Isaac Gabriel Eliaz, Sebastopol CA
Specialties:
Preventive Medicine Specialist
Address:
7064 Corline Ct, Sebastopol, CA 95472
398 Tesconi Ct, Santa Rosa, CA 95401
398 Tesconi Ct, Santa Rosa, CA 95401
Dr. Isaac G Eliaz, Sebastopol CA - MD (Doctor of Medicine)
Specialties:
Public Health & General Preventive Medicine
Address:
Amitabha Medical Clinic and Healing Center
7064 Corline Ct STE A, Sebastopol 95472
(707) 829-5900 (Phone)
7064 Corline Ct STE A, Sebastopol 95472
(707) 829-5900 (Phone)
Languages:
English
Education:
Medical School
Sackler School Of Medicine, Tel Aviv University
Graduated: 1988
Sackler School Of Medicine, Tel Aviv University
Graduated: 1988
Background:
Sanction: 1 time(s)
Compositions And Methods For Treating Mammals With Modified Alginates And Modified Pectins
US Patent:
6462029, Oct 8, 2002
Filed:
Jun 19, 2001
Appl. No.:
09/883329
Inventors:
Isaac Eliaz - Sebastopol CA
Assignee:
Econugenics - Santa Clara CA
International Classification:
A61K 31732
US Classification:
514 54
Abstract:
A modified alginate and/or modified pectin composition for preventing and/or treating diseases and/or conditions caused by circulating agents such as poisonous heavy metals, environmental toxins, calcium and cholesterol, is provided. The composition includes a modified alginate having a molecular weight of no more than 40,000 daltons and/or a modified pectin having a molecular weight of no more than 40,000 daltons. The method involves orally or intravenously administering the modified alginate and/or modified pectin composition, alone or with excipients.
Compositions And Methods For Treating Mammals With Modified Alginates And Modified Pectins
US Patent:
7452871, Nov 18, 2008
Filed:
Nov 28, 2005
Appl. No.:
11/287208
Inventors:
Isaac Eliaz - Sebastopol CA, US
Assignee:
EcoNugenics, Inc. - Santa Rosa CA
International Classification:
A61K 31/715
US Classification:
514 54
Abstract:
A modified alginate and/or modified pectin composition and method for preventing and/or treating diseases and/or conditions caused by circulating agents such as poisonous heavy metals, environmental toxins, calcium and cholesterol, is provided. The composition includes a modified alginate having a molecular weight of no more than 40,000 daltons and/or a modified pectin having a molecular weight of no more than 40,000 daltons. The method involves orally or intravenously administering the modified alginate and/or modified pectin composition, alone or with excipient.
Method For Enhancing Mammalian Immunological Function
US Patent:
8426567, Apr 23, 2013
Filed:
Jul 14, 2006
Appl. No.:
11/485955
Inventors:
Isaac Eliaz - Sebastopol CA, US
Assignee:
Econugenics, Inc. - Santa Rosa CA
International Classification:
C08B 37/06, C08B 37/04, C07H 1/00, A61K 31/732, A61K 31/734
US Classification:
536 2, 536 3, 536124, 514 54
Abstract:
Low molecular weight modified pectin, particularly modified citrus pectin (MCP), and/or low molecular weight modified alginate is useful in a composition for stimulating the immune response of a mammal, particularly a human. Modified pectin and/or modified alginate is administered in a composition in an amount sufficient to modulate, support, enhance or extend an immune response, particularly to an individual having an inadequate or reduced immune function. Stimulation of an immune response is evidenced by stimulation of cell-mediated immune function, humoral immune function, phagocytic function of mononuclear macrophages, and NK cell activity. The composition also may comprise well known pharmacologically acceptable agents, such as sulfured amino acids, cilantro, garlic, minerals, and herbs.
Binding Of Galectin-3 By Low Molecular Weight Pectin
US Patent:
2011029, Dec 1, 2011
Filed:
Jun 6, 2011
Appl. No.:
13/153648
Inventors:
ISAAC ELIAZ - Sebastopol CA, US
International Classification:
A61K 31/732, A61P 35/04, A61P 29/00, A61P 35/00
US Classification:
514 54
Abstract:
Administration of low molecular weight (10,000-20,000 Daltons, or lower) pectins, particularly modified citrus pectins (MCP), like PectaSol-C reduces galectins-3 levels in vivo. Reduction of galectin-3 levels by MCP inhibits inflammation, inhibits fibrosis formation in organs and tissues, and inhibits cancer formation, progression, transformation and metastases. The reduction in circulating, serum and cellular galectin-3, inherently resulting from the administration of MCP, provides benefit over a spectrum of biological conditions, as evidenced by in vivo trials.
Compositions And Methods For Treating Mammals With Modified Alginates And Modified Pectins
US Patent:
7026302, Apr 11, 2006
Filed:
Jul 22, 2002
Appl. No.:
10/199009
Inventors:
Isaac Eliaz - Sebastopol CA, US
Assignee:
Better Health Publishing - Santa Rosa CA
International Classification:
A61K 31/715
US Classification:
514 54
Abstract:
A modified alginate and/or modified pectin composition and method for preventing and/or treating diseases and/or conditions caused by circulating agents such as poisonous heavy metals, environmental toxins, calcium and cholesterol, is provided. The composition includes a modified alginate having a molecular weight of no more than 40,000 daltons and/or a modified pectin having a molecular weight of no more than 40,000 daltons. The method involves orally or intravenously administering the modified alginate and/or modified pectin composition, alone or with excipient.
Compositions And Methods For Treating Diabetes
US Patent:
2007016, Jul 19, 2007
Filed:
Jan 17, 2006
Appl. No.:
11/332237
Inventors:
Isaac Eliaz - Sebastopol CA, US
International Classification:
A61K 31/732, A61K 31/729
US Classification:
514054000
Abstract:
Low molecular weight modified alginate and/or low molecular weight modified pectin, particularly modified citrus pectin (MCP), is useful in a composition for the treatment of diabetes, when administered to a diabetic individual. For instance, a composition comprising MCP is administered to an individual in an amount sufficient to reduce a parameter associated with diabetes severity, particularly levels of total blood glucose or triglyceride. The composition also may comprise well known pharmacologically acceptable agents, such as sulfured amino acids, cilantro, garlic, minerals, and herbs.